NEW YORK, April 19, 2010 (GLOBE NEWSWIRE) -- Laxai Pharma Ltd. (OTCBB:LAXAF) (f/k/a NexGen Biofuels, Ltd.), a contract research organization (“CRO”), recently completed an asset purchase of OSR Solutions, Inc. as a platform acquisition to enter into the CRO industry that provides fully integrated services across the drug development spectrum for pharmaceutical customers and simultaneously cease its biofuel operations.
